Docebo (DCBO) Cost of Revenue (2019 - 2026)

Docebo has reported Cost of Revenue for 8 years, with the latest figure at $14.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 25.96% year-over-year to $14.4 million; the trailing twelve-month figure through Mar 2026 stood at $50.8 million (up 18.81% YoY), and the FY2025 full-year result was $47.9 million, up 15.88% from the prior year.
• Cost of Revenue for Q1 2026 stood at $14.4 million, up from $12.7 million in the prior quarter.
• The five-year high for Cost of Revenue was $14.4 million in Q1 2026, with the low at $6.6 million in Q1 2022.
• Historically, Cost of Revenue has averaged $9.8 million across 5 years, with a median of $9.9 million in 2024.
• Annual changes were most pronounced in 2022 — Cost of Revenue soared 69.57% — and 2025, when it rose 12.94%.
• Docebo's Cost of Revenue stood at $7.5 million in 2022, then gained by 23.28% to $9.3 million in 2023, then gained by 15.07% to $10.6 million in 2024, then grew by 19.62% to $12.7 million in 2025, then rose by 12.66% to $14.4 million in 2026.
• The last three Cost of Revenue figures came in at $14.4 million (Q1 2026), $12.7 million (Q4 2025), and $12.1 million (Q3 2025), per Business Quant data.